Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma

Clinical trial NCT01989052 · TERMINATED

Trial details

NCT number: NCT01989052
Sponsor: Annick Desjardins
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Glioma (WHO Grade III or IV)

Start date: 2014-05-01
Primary completion: 2015-03-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.